WBI Investments LLC bought a new stake in Molina Healthcare, Inc. (NYSE:MOH – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,512 shares of the company’s stock, valued at approximately $621,000.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Team Hewins LLC acquired a new stake in shares of Molina Healthcare in the first quarter worth $204,000. Mediolanum International Funds Ltd acquired a new stake in shares of Molina Healthcare in the first quarter worth $9,911,000. BI Asset Management Fondsmaeglerselskab A S lifted its stake in shares of Molina Healthcare by 69.5% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 11,809 shares of the company’s stock worth $4,851,000 after buying an additional 4,840 shares during the last quarter. Quent Capital LLC lifted its stake in shares of Molina Healthcare by 6.8% in the first quarter. Quent Capital LLC now owns 489 shares of the company’s stock worth $201,000 after buying an additional 31 shares during the last quarter. Finally, Nordea Investment Management AB lifted its stake in shares of Molina Healthcare by 44.0% in the first quarter. Nordea Investment Management AB now owns 26,244 shares of the company’s stock worth $10,852,000 after buying an additional 8,025 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Ronna Romney sold 250 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the sale, the director now owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Molina Healthcare news, COO James Woys sold 10,000 shares of the stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the completion of the sale, the chief operating officer now owns 53,613 shares of the company’s stock, valued at approximately $18,504,526.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronna Romney sold 250 shares of the stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the transaction, the director now owns 16,945 shares in the company, valued at $5,816,710.15. The disclosure for this sale can be found here. 1.11% of the stock is currently owned by company insiders.
Molina Healthcare Stock Up 0.2 %
Molina Healthcare (NYSE:MOH – Get Free Report) last released its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, beating the consensus estimate of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The business had revenue of $9.93 billion during the quarter, compared to analysts’ expectations of $9.45 billion. During the same period last year, the business earned $5.81 earnings per share. The firm’s revenue was up 21.9% on a year-over-year basis. On average, research analysts forecast that Molina Healthcare, Inc. will post 23.56 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Baird R W upgraded shares of Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Stephens reiterated an “equal weight” rating and set a $390.00 target price on shares of Molina Healthcare in a research note on Thursday, April 25th. Robert W. Baird assumed coverage on shares of Molina Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $405.00 target price for the company. Bank of America cut shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price for the company. in a research note on Thursday, March 28th. Finally, JPMorgan Chase & Co. cut their target price on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $405.18.
Check Out Our Latest Stock Analysis on MOH
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
- Five stocks we like better than Molina Healthcare
- Stock Sentiment Analysis: How it Works
- Sales Breakout Sends This Semiconductor Stock to Record High
- Basic Materials Stocks Investing
- Surprise Buying Opportunity on This Dividend Aristocrat
- Buy P&G Now, Before It Sets A New All-Time High
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.